Comments closedIt’s an invisible and new condition. Many people don’t believe that long COVID is real or exists. And unfortunately, that permeates through the healthcare system. Even outside of the medical system, there is a broader societal awareness that is lacking.
Experts and patient groups have warned that the high cost of private Covid vaccinations could exacerbate health inequalities and leave those more at risk from the virus without a vital line of defence.
Both high street chain Boots and pharmacies that partner with the company Pharmadoctor are now offering Covid jabs to those not eligible for a free vaccination through the NHS, with the former charging almost £100 for the Pfizer/BioNTech jab.
While Pharmadoctor says each pharmacy sets its own prices, it suggests the Pfizer/BioNTech jab will set customers back £75-£85, while the latest Novavax jab will cost about £45-£55.
Comments closedExperts worry a recent rise in long COVID cases — fueled by a spike in winter holiday infections and a decline in masking and other measures — could continue into this year.
A sudden rise in long COVID in January has persisted into a second month. About 17.6% of those surveyed by the Census Bureau in January said they have experienced long COVID. The number for February was 17.4.
Compare these new numbers to October 2023 and earlier, when long COVID numbers hovered between 14% and 15% of the US adult population as far back as June 2022.
Comments closedA study of more than 11,000 Australians who tested positive to COVID-19 in 2022 has revealed almost one-in-five were still experiencing ongoing symptoms three months after their initial diagnosis, according to new research from The Australian National University (ANU).
The study was conducted in Western Australia (WA), with participants drawn from the almost 71,000 adults who tested positive to COVID-19 in WA between 16 July 2022 and 3 August 2022.
Lead researcher, Dr Mulu Woldegiorgis, said the results show the risk of developing long COVID from the Omicron variant is higher than previously thought.
Comments closedThe Omicron coronavirus variant could be causing more cases of long COVID than earlier versions of the disease, scientists say.
A study of more than 11,000 Western Australians infected in 2022 found almost one in five continued to suffer symptoms three months after they initially tested positive.
Epidemiologist Mulu Woldegiorgis said the findings show the Omicron variant puts patients at greater risk of developing long COVID than previously thought.
“It is more than double the prevalence reported in a review of Australian data from earlier in the pandemic, and higher than similar studies done in the UK and Canada,” she said on Thursday.
Comments closedA study today in Clinical Infectious Diseases conducted across 12 tertiary care pediatric hospitals in Canada and the United States shows that asymptomatic children with COVID-19, especially preschoolers, contribute significantly to household transmission.
The researchers discovered that 10.6% of exposed household contacts developed symptomatic illness within 14 days of exposure to asymptomatic test-positive children, a rate higher than expected.
“We determined that the risk of developing symptomatic illness within 14 days was 5 times greater among household contacts of asymptomatic SARS-CoV-2–positive children,” the authors wrote.
They also found that 6 of 77 asymptomatic SARS-CoV-2–infected children during a 3-month follow-up developed long COVID, or 7.8% of them.
Comments closedComments closedSome people who had Long Covid early in 2020 are still not well. So the experience of being not listened to and not believed has been very harmful for them alongside the very considerable health impacts that they’ve had from Long Covid. […] The cost of inaction is going to be very high and that’s going to be a human cost and a financial cost.
Comments closedTaken together, these studies show that COVID-19 poses a serious risk to brain health, even in mild cases, and the effects are now being revealed at the population level. […]
The growing body of research now confirms that COVID-19 should be considered a virus with a significant impact on the brain. The implications are far-reaching, from individuals experiencing cognitive struggles to the potential impact on populations and the economy.
A new report by global economics consultancy Cambridge Econometrics reveals that Long Covid could have wider economic ramifications for the UK causing a drag on economic growth and added pressure on the NHS if no long-term healthcare funding commitments are made.
Funded by direct giving fund Balvi, and in partnership with Professor Emeritus in Public Health Ruairidh Milne from the University of Southampton, the report used available evidence on the cost of Long Covid treatment, economic inactivity among those living with the condition, and prevalence in the UK population to consider the long-term macroeconomic impacts on wider UK society by 2030.
Based on the assumption that there are no long-term healthcare funding commitments to manage Long Covid, the results estimate that Long Covid is likely to reduce GDP by around £1.5bn and 138,000 jobs each year. Were prevalence to increase to 4 million people per year by 2030, the negative impacts would increase to a reduction of around £2.7bn in GDP and 311,000 job losses each year.
Comments closedA dedicated sick pay scheme for people suffering from the effects of “long Covid” is due to end in two weeks’ time in a move which will affect around 120 healthcare workers.
In July 2022 the Government introduced a temporary scheme to provide special leave with pay for eligible staff suffering with the symptoms of long Covid, such as fatigue and exhaustion. While the scheme was previously extended following approval by the Department of Public Expenditure, it will now end on March 31st. The Department of Public Expenditure has told the Department of Health that no further extensions will be granted.
Comments closedCBC Calgary’s weekly health columnist, Dr. Raj Bhardwaj, discusses what we’ve learned and how far we’ve come with science and treatments since the start of the COVID-19 pandemic.
Comments closed